KENDRA PAULEY: Open Payments
NPI 1720792617 · KANKAKEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 22 payments from 14 companies in 2025. Trend: 2023 $140 · 2024 $431 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $103 |
| GENZYME CORPORATION | 2 | $84 |
| ARGENX US, INC. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| UCB, Inc. | 1 | $35 |
| Biogen, Inc. | 2 | $29 |
| Eisai Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| KYOWA KIRIN, INC. | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
Products named: UBRELVY, VYVGART, WAINUA, Nayzilam, SKYCLARYS, BOTOX, Leqembi, ACTHAR.
Industry payments across IL — which companies pay providers there.
